113333-04-3 Usage
Anti-inflammatory and analgesic properties
Known for its ability to reduce inflammation and relieve pain
Used in pharmaceutical industry
Often used in the development of pain-relief medications
Piperazinedione derivative
A compound derived from a piperazinedione base
Z configuration
Refers to the geometric isomerism of the compound, affecting its chemical and biological properties
Yellow to brownish solid
The physical appearance of the compound at room temperature
Potential therapeutic applications
Used in research and development for its potential as a therapeutic agent
Further studies needed
Additional studies and clinical trials are required to fully understand the potential uses and risks of 2,5-Piperazinedione,
1-acetyl-3-[[2-(methoxymethoxy)phenyl]methylene]-, (Z)-.
Check Digit Verification of cas no
The CAS Registry Mumber 113333-04-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,3,3 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 113333-04:
(8*1)+(7*1)+(6*3)+(5*3)+(4*3)+(3*3)+(2*0)+(1*4)=73
73 % 10 = 3
So 113333-04-3 is a valid CAS Registry Number.
113333-04-3Relevant academic research and scientific papers
Convenient Synthesis of 3-Aminocoumarin Derivatives by the Condensation of 1,4-Diacetyl- or 3-Substituent-2,5-piperazinediones with Various Salicylaldehyde Derivatives
Shin, Chung-gi,Nakajima, Yoshiharu,Haga, Toshiya,Sato, Yoshiaki
, p. 3917 - 3924 (2007/10/02)
The condensation of 1,4-diacetyl- or 3-substituted 2,5-piperazinediones (PDO) with various salicylaldehyde derivatives in the presence of a base, such as potassium t-butoxide or triethylamine, was found to give two extremely different kind of products: 1-acetyl-3-arylmethylene-PDO and 3-(acylamino)coumarin derivatives.The former, which has a (Z)-geometric structure, was readily converted to the latter by irradiation.Furthermore, the conversion mechanism and the structural confirmation are discussed.
